Indeed, DLBCL patients with high PATZ1 levels had significantly better OS and PFS compared with DLBCL patients with low PATZ1 (p = 0.020 and 0.002, respectively; Figure 7A–7B). Here, PATZ1 is linked to diffuse large B-cell lymphoma.